CCL20 and hepatocellular carcinoma: Consistent with the results from the bioinformatic analysis, HOXD3 was found to upregulate the expression of Med15 and CCL20 in HCC cells (Fig. 8M–N) and directly bind to the promoter region of Med15 (Fig. 8O, P).